GTBP GT Biopharma, Inc.
Nasdaq · SEC CIK 109657 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 26 since 2021-10-07, latest 2025-09-08
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 15
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | 2023-08-11 | GTBP | Breen Michael Martin | Executive COB, Interim CEO, Dir | A - Grant | $0.29 | +200.0K | 856.2K | +30% | +$58.0K | |
| I | 2023-08-15 | 2023-08-11 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.29 | +200.0K | 300.0K | +200% | +$58.0K |
| 2023-08-15 | 2023-08-11 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.29 | -200.0K | 0 | -100% | -$58.0K | |
| 2023-08-15 | 2023-08-11 | GTBP | Ohri Manu | CFO, Sec | A - Grant | $0.29 | +200.0K | 200.0K | New | +$58.0K | |
| 2023-04-11 | 2023-04-11 | GTBP | Breen Michael Martin | Executive COB, Interim CEO, Dir | P - Purchase | $0.5 | +50.0K | 656.2K | +8% | +$25.0K | |
| I | 2023-04-10 | 2023-04-06 | GTBP | Ohri Manu | CFO, Sec | P - Purchase | $0.5 | +50.0K | 50.0K | New | +$25.0K |
| D | 2022-07-19 | 2022-07-15 | GTBP | Breen Michael Martin | Exec. COB, Interim CEO, Dir | A - Grant | $0.00 | +278.1K | 606.2K | +85% | $0 |
| D | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.00 | -100.0K | 0 | -100% | $0 |
| DI | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2022-02-14 | 2021-02-16 | GTBP | Berk Gregory | Dir | A - Grant | $0.00 | +278.1K | 278.1K | New | $0 |
| DM | 2021-11-12 | 2021-02-25 | GTBP | Breen Michael Martin | Dir | C - Cnv Deriv | $3.40 | +50.1K | 318.3K | +19% | +$170.3K |
| D | 2021-11-12 | 2021-02-16 | GTBP | Breen Michael Martin | Dir | A - Grant | $0.00 | +278.1K | 278.1K | New | $0 |
| D | 2021-10-07 | 2021-02-16 | GTBP | Wendel Bruce | Dir | A - Grant | $0.00 | +347.6K | 352.7K | +6,838% | $0 |
| DM | 2021-10-07 | 2020-11-16+ | GTBP | Wendel Bruce | Dir | P - Purchase | $5.17 | +5,083 | 4,642 | New | +$26.3K |
Purchase Sale Sale after option exercise All abbreviations